Company page
Swedish Orphan Biovitrum Ab
Swedish Orphan Biovitrum Ab (SOBI) is a public company based in Sweden, focusing on developing and delivering innovative treatments for rare diseases. With a market capitalization of approximately 15.79 billion USD, SOBI is committed to improving patient outcomes through its specialized therapies. The company operates in a competitive market, emphasizing its dedication to addressing unmet medical needs.
- Ticker
- SOBI:OMXSTO
- Asset type
- Stock
- Market cap
- $15.79B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK